AKT1 and non-small cell lung carcinoma: LA also promoted the degradation of EGFR, Met, Her2, and Akt through inactivating EGFR/Met-Akt signaling, resulting in apoptosis of gefitinib-resistant NSCLC cells (H1975) (Seo, 2013).